These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37021471)

  • 1. Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease.
    Piloni D; Ottaviani S; Saderi L; Corda L; Baderna P; Barzon V; Balderacchi AM; Seebacher C; Balbi B; Albicini F; Corino A; Mennitti MC; Tirelli C; Spreafico F; Bosio M; Mariani F; Sotgiu G; Corsico AG; Ferrarotti I
    Minerva Med; 2024 Feb; 115(1):23-31. PubMed ID: 37021471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.
    Serban KA; Pratte KA; Strange C; Sandhaus RA; Turner AM; Beiko T; Spittle DA; Maier L; Hamzeh N; Silverman EK; Hobbs BD; Hersh CP; DeMeo DL; Cho MH; Bowler RP
    EBioMedicine; 2022 Oct; 84():104262. PubMed ID: 36155958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
    Barjaktarevic I; Miravitlles M
    BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ.
    Franciosi AN; Carroll TP; McElvaney NG
    Thorax; 2021 Mar; 76(3):298-301. PubMed ID: 32917839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis.
    Veith M; Tüffers J; Peychev E; Klemmer A; Kotke V; Janciauskiene S; Wilhelm S; Bals R; Koczulla AR; Vogelmeier CF; Greulich T
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2827-2836. PubMed ID: 33192056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of alleles and genotypes associated with alpha-1 antitrypsin deficiency in clinical and general populations: Revelations about underdiagnosis.
    Hernández-Pérez JM; Ramos-Díaz R; Vaquerizo-Pollino C; Pérez JA
    Pulmonology; 2023; 29(3):214-220. PubMed ID: 35346640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
    Beletic A; Dudvarski-Ilic A; Milenkovic B; Nagorni-Obradovic L; Ljujic M; Djordjevic V; Mirkovic D; Radojkovic D; Majkic-Singh N
    Biochem Med (Zagreb); 2014; 24(2):293-8. PubMed ID: 24969923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil.
    Russo R; Zillmer LR; Nascimento OA; Manzano B; Ivanaga IT; Fritscher L; Lundgren F; Miravitlles M; Gondim HD; Santos G; Alves MA; Oliveira MV; Souza AA; Sales MP; Jardim JR
    J Bras Pneumol; 2016; 42(5):311-316. PubMed ID: 27812629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.
    Franciosi AN; Hobbs BD; McElvaney OJ; Molloy K; Hersh C; Clarke L; Gunaratnam C; Silverman EK; Carroll TP; McElvaney NG
    Am J Respir Crit Care Med; 2020 Jul; 202(1):73-82. PubMed ID: 32197047
    [No Abstract]   [Full Text] [Related]  

  • 10. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center Experience.
    Evers G; Schulze AB; Thrull M; Hering JP; Schülke C; Wiewrodt R; Wittkowski H; Schmidt LH; Mohr M
    Can Respir J; 2020; 2020():4019608. PubMed ID: 32566054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha1-antitrypsin deficiency: An updated review.
    Mornex JF; Traclet J; Guillaud O; Dechomet M; Lombard C; Ruiz M; Revel D; Reix P; Cottin V
    Presse Med; 2023 Sep; 52(3):104170. PubMed ID: 37517655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction.
    Rahaghi FF; Sandhaus RA; Brantly ML; Rouhani F; Campos MA; Strange C; Hogarth DK; Eden E; Stocks JM; Krowka MJ; Stoller JK
    COPD; 2012 Aug; 9(4):352-8. PubMed ID: 22506682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1 Antitrypsin Deficiency and Tobacco Smoking: Exploring Risk Factors and Smoking Cessation in a Registry Population.
    Franciosi AN; Alkhunaizi MA; Woodsmith A; Aldaihani L; Alkandari H; Lee SE; Fee LT; McElvaney NG; Carroll TP
    COPD; 2021 Feb; 18(1):76-82. PubMed ID: 33557645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey.
    Tural Onur S; Natoli A; Dreger B; Arınç S; Sarıoğlu N; Çörtük M; Karadoğan D; Şenyiğit A; Yıldız BP; Köktürk N; Argun Barıs S; Kodalak Cengiz S; Polatli M
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2785-2794. PubMed ID: 38046982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease.
    Blanco I; Diego I; Castañón C; Bueno P; Miravitlles M
    Arch Bronconeumol; 2023 Jul; 59(7):427-434. PubMed ID: 37045725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group.
    Greulich T; Albert A; Cassel W; Boeselt T; Peychev E; Klemmer A; Ferreira F; Clarenbach C; Torres-Duran ML; Turner AM; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2022; 17():53-64. PubMed ID: 35023913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals.
    Lara B; Miravitlles M
    COPD; 2015 May; 12 Suppl 1():27-31. PubMed ID: 25938288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
    Lascano JE; Campos MA
    Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.